Application of thrombin gel matrix for the prevention of lymphocele in patients with endometrial cancer: A prospective randomized trial
To evaluate a thrombin gel matrix (TGM), Floseal, for the prevention of lymphocele in patients with endometrial cancer who underwent pelvic lymphadenectomy. A total of 79 consecutive patients with endometrial cancer were randomly allocated to one of two groups: the TGM group and control group. After...
Gespeichert in:
Veröffentlicht in: | Journal of gynecology obstetrics and human reproduction 2021-09, Vol.50 (7), p.101994-101994, Article 101994 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!